fsr
Home Press Releases Investors Only Team Contact Career

Charleston Business Journal:
Sept. 8th, 2010
FirstString Research Completes Phase I Clinical Trials
“This trial, in 48 human subjects, has successfully demonstrated the safety and early efficacy of our compound", said the Chief Executive Dr. Ghatnekar.

»Read More

Contact Us

FirstString Research, Inc.
475-A East Bay Steet
Charleston, SC 29403
Ph: 843-860-8372
Fax: 843-720-3835
info@firststringresearch.com


Phone 843-860-8372
Fax 843-720-3835
e-mail info@firststringresearch.com

 

Please complete the form below to email us.
Your Name:
Your Email:
Your Telephone:
Select Subject :
How can we contact you?
Message:

 

  
Home | Press Releases | Team | Investors Only | Contact

THIS PRODUCT IS NOT AVAILABLE FOR SALE AND IS NOT APPROVED FOR DISTRIBUTION IN THE UNITED STATES BY THE FDA.